Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) ANTIGEN

Geisinger Epic Procedure Code:  LAB2855    Geisinger Epic ID:  39189

SPECIMEN COLLECTION
Specimen type: 

Citrated plasma


Preferred collection container: 
Specimen required: 

1 mL frozen citrated plasma; minimum 0.5 mL



SPECIMEN PROCESSING
Processing instructions: 

Spin down, remove plasma, and spin plasma again. Aliquot into clean tube. Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and ship on dry ice.


Transport temperature: 

Frozen


Specimen stability: 

Frozen -20°C: 30 days. Frozen -70°C: 1 year.


Rejection criteria: 

Specimen not frozen.



TEST DETAILS
CPT code(s):  85415
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Methodology: 
Enzyme-Linked Immunosorbent Assay (ELISA)
Synonyms: 

PAI, PIA-1, plasma activator inhibitor antigen, Quest test code 36555, PAIAG


Clinical significance: 

Increased activity is associated with increased risk of arterial thrombosis, such as with unexplained premature myocardial infarction. As an acute phase reactant, the activity is increased after an acute event. Studies suggest PAI-1 may be a prognostic marker in early stage breast cancer.


Review Date:  12/16/2024

Performing Locations